Biological Functions of the BRCA1 and BRCA2 Proteins

作者: Helen K. Chew , Andrew A. Farmer , Wen-Hwa Lee

DOI: 10.1007/978-1-59259-456-6_10

关键词:

摘要: Breast cancer is the most commonly diagnosed nondermatologic in women United States. It second only to lung as frequent cause of cancer-related deaths American women. In 1996, Cancer Society projected over 184,000 newly cases breast and 44,000 secondary invasive (1). The average woman has a 1:8 lifetime risk developing cancer. undoubtedly one common malignancies Western world, yet there currently no cure for metastatic For this reason, tremendous effort been focused on prevention early diagnosis

参考文章(90)
D T Bishop, D F Easton, D Ford, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 265- 271 ,(1995)
William A. Cliby, Karl C. Podratz, Gary L. Keeney, Karen A. DeLacey, Mark K. Dodson, Robert B. Jenkins, Hong Ji Xu, William F. Benedict, Shi Xue Hu, Jian Li, Evidence of Functional RB Protein in Epithelial Ovarian Carcinomas despite Loss of Heterozygosity at the RB Locus Cancer Research. ,vol. 54, pp. 610- 613 ,(1994)
T R Rebbeck, K Calzone, M DeShano, B L Weber, J E Garber, Y Peng, F J Couch, K Chen, J Kant, Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. American Journal of Human Genetics. ,vol. 59, pp. 547- 553 ,(1996)
Andrew Berchuck, Gudrun Huper, Frank D. Cirisano, P. Andrew Futreal, J. Dirk Iglehart, Jeffrey R. Marks, James P. Vaughn, Cell Cycle Control of BRCA2 Cancer Research. ,vol. 56, pp. 4590- 4594 ,(1996)
Louis Dubeau, Mihaela Velicescu, Gerrit D'Ablaing, Timothy M. Kim, Jianping Zheng, Hong-Ji Xu, Eric Yin, William F. Benedict, Jim Gosewehr, Shi-Xue Hu, Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Research. ,vol. 54, pp. 605- 609 ,(1994)
Wen-Hwa Lee, Andrew A. Farmer, Diane C. Jones, Phang-Lang Chen, Yumay Chen, Chi-Fen Chen, BRCA1 Is a 220-kDa Nuclear Phosphoprotein That Is Expressed and Phosphorylated in a Cell Cycle-dependent Manner Cancer Research. ,vol. 56, pp. 3168- 3172 ,(1996)
Bienstock Rj, Barrett Jc, Darden T, Wiseman R, Pedersen L, Molecular Modeling of the Amino-Terminal Zinc Ring Domain of BRCA1 Cancer Research. ,vol. 56, pp. 2539- 2545 ,(1996)
Peer Bork, Kay Hofmann, Philipp Bucher, Andrew F. Neuwald, Stephen F. Altschul, Eugene V. Koonin, A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. The FASEB Journal. ,vol. 11, pp. 68- 76 ,(1997) , 10.1096/FASEBJ.11.1.9034168
McManus R, Easton Df, Ormiston W, Daly Pa, Seal S, Wooster R, Collins N, Ford D, Mangion J, Lakhani, Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. ,vol. 10, pp. 1673- 1675 ,(1995)
Dominique Stoppa-Lyonnet, Fabienne Kerangueven, Brigitte Bressac-de-Paillerets, Tetsuro Noguchi, Jocelyne Jacquemier, Jean-Marc Guinebretiere, Hagay Sobol, François Eisinger, Daniel Birnbaum, Nicolas Janin, Jean-Philippe Peyrat, Truncation at Conserved Terminal Regions of BRCA1 Protein Is Associated with Highly Proliferating Hereditary Breast Cancers Cancer Research. ,vol. 56, pp. 3216- 3219 ,(1996)